Executive Vice President, Chief Medical and Science Officer
Mirjam joined Ferring Pharmaceuticals as Senior Vice President for Global Development in January 2018 and has held the position of Chief Science and Medical Officer since July 2020. She is responsible for overseeing Ferring’s research and development, real world evidence, global pharmacovigilance, and global medical affairs activities.
Mirjam has over 30 years’ global experience across research, medical, clinical development and portfolio management, and previously held senior leadership positions at Solvay Pharmaceuticals, Schering-Plough, Organon, and MSD. Most recently, she was Chief Executive Officer of a newly established science park which focused on pharmaceutical innovation in the Netherlands.
Mirjam graduated as a medical doctor from Utrecht University in the Netherlands.